Stock-Based Compensation for Merck & Co. (MRK)
Stock-Based Compensation for Merck & Co. (MRK): headline value $615.00M · YoY -100.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
MRK
Currently viewingStock-Based CompensationSwitch metric
Latest period
$615.00M
YoY change
-100.0%
5Y CAGR
-100.0%
Peak year (2024)
$761.00M
Latest annual
$0
Stock-Based Compensation history chart for Merck & Co. (MRK) from 1989 to 2025
Stock-Based Compensation history table for Merck & Co. (MRK) from 1989 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $0 | -100.0% | ||
| 2024 | $761.00M | +18.0% | ||
| 2023 | $645.00M | +19.2% | ||
| 2022 | $541.00M | +12.9% | ||
| 2021 | $479.00M | +8.6% | ||
| 2020 | $441.00M | +5.8% | ||
| 2019 | $417.00M | +19.8% | ||
| 2018 | $348.00M | +11.5% | ||
| 2017 | $312.00M | +4.0% | ||
| 2016 | $300.00M | +0.3% | ||
| 2015 | $299.00M | +7.6% | ||
| 2014 | $278.00M | +0.7% | ||
| 2013 | $276.00M | -17.6% | ||
| 2012 | $335.00M | -9.2% | ||
| 2011 | $369.00M | -27.5% | ||
| 2010 | $509.00M | +22.5% | ||
| 2009 | $415.50M | +89.7% | ||
| 2008 | $219.00M | +3.8% | ||
| 2007 | $211.00M | +25.6% | ||
| 2006 | $168.00M | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — | ||
| 1990 | $0 | — | ||
| 1989 | $0 | — |
Stock-Based Compensation values are taken from Merck & Co.'s reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Merck & Co. (MRK) most recent annual stock-based compensation stands at $0 (2025) – plunged 100.0% year-over-year.
Merck & Co. stock-based compensation compound annual growth for the 2020–2025 (5 years) window is -100.0%, with a net decline across the window.
2024 marks the peak stock-based compensation at $761.00M, with the historical low of $0 recorded in 1989.
Merck & Co. (MRK) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of $313.00M.
Merck & Co. Stock-Based Compensation by Year
Merck & Co. Stock-Based Compensation 2025: $0
Merck & Co. stock-based compensation in 2025 was $0, plunged 100.0% below 2024.
Merck & Co. Stock-Based Compensation 2024: $761.00M
Merck & Co. stock-based compensation in 2024 was $761.00M, grew 18.0% from 2023. This figure represents the highest annual value in the available history.
Merck & Co. Stock-Based Compensation 2023: $645.00M
Merck & Co. stock-based compensation in 2023 was $645.00M, grew 19.2% from 2022.
Merck & Co. Stock-Based Compensation 2022: $541.00M
Merck & Co. stock-based compensation in 2022 was $541.00M, grew 12.9% from 2021.
Merck & Co. Stock-Based Compensation 2021: $479.00M
Merck & Co. stock-based compensation in 2021 was $479.00M.
See more financial history for Merck & Co. (MRK).
Sector peers — Stock-Based Compensation
Companies in the same sector as Merck & Co., ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $0 | Healthcare |
Frequently asked questions
What is Merck & Co.'s stock-based compensation?
Latest reported stock-based compensation for Merck & Co. (MRK) is $615.00M (period ending December 31, 2025).
How has Merck & Co. stock-based compensation changed year-over-year?
Merck & Co. (MRK) stock-based compensation changed -100.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Merck & Co. stock-based compensation?
Merck & Co. (MRK) stock-based compensation compound annual growth rate is -100.0% over the most recent 5 years available.
When did Merck & Co. stock-based compensation hit its highest annual value?
Merck & Co. stock-based compensation reached its highest annual value of $761.00M in 2024.
What was Merck & Co. stock-based compensation in 2024?
Merck & Co. (MRK) stock-based compensation in 2024 was $761.00M.
What was Merck & Co. stock-based compensation in 2025?
Merck & Co. (MRK) stock-based compensation in 2025 was $0.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
MRK Overview
Company profile, financial tools, and key metrics
MRK Revenue Counter
Earns $2,061 every second. See per minute, hour, and day.
MRK Earnings Counter
Earns $578.83 per second net profit. See per minute, hour, and day.
MRK Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
MRK What If Invested
What if you had invested $1,000? See historical returns from any date.
MRK How It Makes Money
Discover visual breakdown of $65.01B in revenue — where it comes from and where it goes.
MRK Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRK Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRK Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
MRK Buybacks
2.39% TTM buyback yield. Shareholder yield & SBC comparison.
MRK Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
MRK Dividend Profile
Yield: 2.99%. Safety: 8/8. See full history.
MRK Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
MRK Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.